Holen Sie sich die Stockscreener-App
31.36
1.57%
-0.50
Schlusskurs vom Vortag:
$31.86
Offen:
$31.76
24-Stunden-Volumen:
1.03M
Relative Volume:
0.85
Marktkapitalisierung:
$2.75B
Einnahmen:
$23.38M
Nettoeinkommen (Verlust:
$-155.22M
KGV:
-14.32
EPS:
-2.19
Netto-Cashflow:
$-134.36M
1W Leistung:
-3.12%
1M Leistung:
+13.46%
6M Leistung:
+49.83%
1J Leistung:
+9.65%
1-Tages-Spanne:
$30.57
$32.02
1-Wochen-Bereich:
$30.57
$33.64
52-Wochen-Spanne:
$13.45
$33.64
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Firmenname
Ideaya Biosciences Inc
Sektor
Branche
Telefon
650-443-6209
Adresse
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie IDYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
31.36 | 2.79B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-09-04 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Eingeleitet | TD Cowen | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-26 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-11-05 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2024-03-08 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | SVB Securities | Outperform |
| 2023-05-24 | Eingeleitet | Goldman | Buy |
| 2023-04-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-23 | Eingeleitet | Berenberg | Buy |
| 2023-02-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-28 | Eingeleitet | CapitalOne | Overweight |
| 2022-10-27 | Eingeleitet | Citigroup | Buy |
| 2022-08-15 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-11 | Eingeleitet | Guggenheim | Buy |
| 2020-10-07 | Eingeleitet | Wedbush | Outperform |
| 2020-09-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-17 | Eingeleitet | Citigroup | Buy |
| 2019-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2019-06-17 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten
Why IDEAYA Biosciences Inc. stock appeals to analystsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Using AI based signals to follow IDEAYA Biosciences Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - newser.com
Is IDEAYA Biosciences Inc. stock a top momentum play2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
How IDEAYA Biosciences Inc. stock reacts to Fed rate cuts2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
How to integrate IDEAYA Biosciences Inc. into portfolio analysis tools2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Why IDEAYA Biosciences Inc. (30J) stock benefits from AI revolutionJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
News impact scoring models applied to IDEAYA Biosciences Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth story2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com
What MACD signals say about IDEAYA Biosciences Inc.2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Will IDEAYA Biosciences Inc. stock see PE expansion2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
IDEAYA Biosciences Inc. stock trend forecastEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryEntry Point & Advanced Technical Signal Analysis - newser.com
Institutional scanner results for IDEAYA Biosciences Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - newser.com
Can IDEAYA Biosciences Inc. stock sustain revenue growthTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com
Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimates2025 Dividend Review & Community Supported Trade Ideas - newser.com
IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events - Sahm
Is IDEAYA Biosciences Inc. stock in correction or buying zoneWeekly Risk Report & Consistent Profit Alerts - newser.com
Order flow analysis tools used on IDEAYA Biosciences Inc.2025 Market Sentiment & Safe Entry Trade Reports - newser.com
AlphaQuest LLC Sells 16,763 Shares of IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Will IDEAYA Biosciences Inc. stock remain a Wall Street favoriteMarket Volume Report & Weekly High Momentum Picks - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Upgraded at Wall Street Zen - MarketBeat
Using flow based indicators on IDEAYA Biosciences Inc.July 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
IDEAYA Biosciences (NASDAQ: IDYA) awards 73,500 inducement options with 4-year vesting - Stock Titan
Visualizing IDEAYA Biosciences Inc. stock with heatmapsJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Can IDEAYA Biosciences Inc. (30J) stock attract ESG investmentsMarket Activity Recap & Real-Time Market Trend Scan - newser.com
Clinical Trial Success Propels Ideaya Biosciences Shares to New Heights - AD HOC NEWS
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):